- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Veracyte Inc (VCYT)
Track today's live Veracyte Inc (VCYT) share price, performance and key data on this page with our current NASDAQ:VCYT stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Veracyte Inc share price on the NASDAQ exchange. Use the dropdown to switch exchange for the VCYT share price, head to our technical summary section, which provides analysis on Veracyte Inc share price buy/sell indicators using real-time data (or discuss the Veracyte Inc (VCYT) stock price today with other investors in the Veracyte Inc NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:VCYT share price (ISIN: US92337F1075) to enhance your trading decisions with our free investment tools and resources.
What Is the Veracyte Inc Share Price Today?
The Veracyte Inc share price today is 42.60.
What Is the Stock Symbol for Veracyte Inc
The stock symbol (or 'ticker') for Veracyte Inc is "VCYT."
What Stock Exchange Does Veracyte Inc Trade On?
Veracyte Inc is listed and trades on the NASDAQ stock exchange.
Is Veracyte Inc a Good Stock to Buy?
Determining whether Veracyte Inc (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:VCYT share price (ISIN: US92337F1075) to enhance your trading decisions with our free investment tools and resources.
What Is the Veracyte Inc Share Price Today?
The Veracyte Inc share price today is 42.60.
What Is the Stock Symbol for Veracyte Inc
The stock symbol (or 'ticker') for Veracyte Inc is "VCYT."
What Stock Exchange Does Veracyte Inc Trade On?
Veracyte Inc is listed and trades on the NASDAQ stock exchange.
Is Veracyte Inc a Good Stock to Buy?
Determining whether Veracyte Inc (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.51
45.23
52 wk Range
28.25
60.91
VCYT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.5145.23
52 wk Range
28.2560.91
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VCYT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
57.82
Upside
+35.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Veracyte Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
Veracyte Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Veracyte Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Veracyte Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Veracyte Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
10 Buy
1 Hold
1 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 57.82
(+35.72% Upside)
Veracyte Inc Earnings Call Summary for Q2/2026
- Veracyte posted Q2 adjusted EPS of $0.54 vs. $0.43 est., revenue of $150.3M vs. $144.6M est.; shares fell 7.58% after hours despite beat.
- Revenue rose 15% YoY; non-GAAP gross margin expanded 340bps to 74.9%; adjusted EBITDA reached 29.2% of revenue, above 25% long-term target.
- Company raised FY 2026 revenue guidance to $590M-$596M from $582M-$592M, implying 14-15% growth; adjusted EBITDA guidance held above 26%.
- Launched Prosigna LDT and TrueMRD for bladder cancer in Q2; Prosigna revenue excluded from guidance pending Medicare reimbursement finalization.
- Decipher volume guidance trimmed due to low-risk testing weakness after guideline changes; expanding sales force to 15 reps to support new product adoption.
Last Updated: 30/07/2026, 22:44
Read Full TranscriptEarnings
Latest Release
30/07/2026
EPS / Forecast
0.54 / 0.43
Revenue / Forecast
150.32M / 144.56M
Compare VCYT to Peers and Sector
Metrics to compare | VCYT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVCYTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 29.9x | 21.1x | −0.4x | |
PEG Ratio | 0.09 | 0.70 | 0.00 | |
Price/Book | 2.5x | 2.3x | 2.6x | |
Price / LTM Sales | 6.1x | 2.2x | 3.1x | |
Upside (Analyst Target) | 29.2% | 25.3% | 48.4% | |
Fair Value Upside | Unlock | 8.7% | 6.5% | Unlock |
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Veracyte Inc (NASDAQ: VCYT) Share Price Today?
The Veracyte Inc stock price today is 42.60 USD.
What Stock Exchange Does Veracyte Inc (VCYT) Trade On?
Veracyte Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Veracyte Inc?
The stock symbol (also called a 'ticker') for Veracyte Inc is "VCYT."
What Is the Current Veracyte Inc Market Capitalisation?
As of today, Veracyte Inc (NASDAQ: VCYT) market cap is 3.42B USD.
What Is Veracyte Inc's (VCYT) Earnings Per Share (TTM)?
The Veracyte Inc EPS is currently 1.39 (Trailing Twelve Months).
When Is the Next Veracyte Inc Earnings Date?
Veracyte Inc's next earnings report will be released on 10/11/2026.
Is VCYT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Veracyte Inc moving averages and other technical indicators, the daily buy/sell signal for VCYT stock is Strong Sell.
How Many Times Has Veracyte Inc Stock Split?
Veracyte Inc has split 0 times. (See the VCYT stock split history page for full effective split date and price information.)
How Many Employees Does Veracyte Inc Have?
Veracyte Inc has 755 employees, based on their latest Companies House report.
What is the current trading status of Veracyte Inc (NASDAQ: VCYT)?
As of 14/08/2026, Veracyte Inc (VCYT) is trading at a share price of 42.60 USD, with a previous close of 44.68 USD. The stock has fluctuated within a day range of 42.51 USD to 45.23 USD, while its 52-week range spans from 28.25 USD to 60.91 USD.
What Is Veracyte Inc (VCYT) Price Target According to Analysts?
The average 12-month price target for Veracyte Inc is 57.82 USD, with a high estimate of 70 USD and a low estimate of 44 USD. 10 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +35.72% Upside potential.
What Is the VCYT Premarket Price?
VCYT's last pre-market stock price is 45.20 USD. The pre-market share volume is 1,380.00, and the stock has decreased by 0.52, or 1.16%.
What Is the VCYT After Hours Price?
VCYT's last after hours stock price is 42.75 USD, the stock has decreased by 0.15, or 0.35%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.